phenylbutazone has been researched along with rifampin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (55.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Floersheim, GL | 4 |
| Gugler, R | 1 |
| Christensen, LK; Hansen, JM | 1 |
| Burrows, GE; Burrows, SL; Ewing, P; MacAllister, CG; Stair, E | 1 |
| Gray, GD; Ohlmann, GM | 1 |
| Black, J; Burrows, GE; MacAllister, CG; Tripp, P | 1 |
| Berthelot, P | 1 |
| Arrigoni-Martelli, E; Schiatti, P; Selva, D | 1 |
| Greim, H | 1 |
| Gibson, GG; Goldfarb, PS; Gray, TJ; Ogg, MS; Tarbit, M; Williams, JM | 1 |
5 review(s) available for phenylbutazone and rifampin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
[Experimental basis for the therapy of Amanita phalloides poisoning].
Topics: Amanita; Animals; Carbon Tetrachloride; Charcoal; Common Bile Duct; Cytochrome c Group; Drainage; Drug Synergism; Flavonoids; Humans; Mice; Mushroom Poisoning; Penicillins; Phalloidine; Phenylbutazone; Prednisolone; Rats; Renal Dialysis; Rifampin; Silymarin; Thioctic Acid | 1978 |
Drug interactions with oral sulphonylurea hypoglycaemic drugs.
Topics: Allopurinol; Analgesics; Anticoagulants; Chloramphenicol; Chlorpropamide; Disulfiram; Drug Interactions; Ethanol; Glyburide; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Monoamine Oxidase Inhibitors; Novobiocin; Phenylbutazone; Phenytoin; Probenecid; Propranolol; Rifampin; Sulfonamides; Sulfonylurea Compounds; Tolbutamide | 1977 |
Mechanisms and prediction of drug-induced liver disease.
Topics: Adenosine Triphosphate; Age Factors; Animals; Bilirubin; Biotransformation; Carbon Isotopes; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Chlordiazepoxide; Chlorpromazine; Cholestasis; Dogs; Humans; Infant, Newborn; Liver; Liver Diseases; Mice; Microsomes, Liver; Phenylbutazone; Rats; Rifampin; RNA | 1973 |
[Enzyme induction in the liver changes drug activity].
Topics: Animals; Barbiturates; Carbamazepine; Chlorpromazine; Drug Interactions; Enzyme Induction; Glutethimide; Humans; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Rifampin; Time Factors | 1980 |
15 other study(ies) available for phenylbutazone and rifampin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Antagonistic effects against single lethal doses of Amanita phalloides.
Topics: Agaricales; Amanita; Amanitins; Animals; Antidotes; Carbon Tetrachloride; Cytochrome c Group; Female; Mice; Mushroom Poisoning; Peptides, Cyclic; Phalloidine; Phenylbutazone; Plant Extracts; Prednisolone; Rifampin; Silymarin; Thioctic Acid | 1976 |
[Drug interactions in therapy using coumarin derivatives].
Topics: Allopurinol; Anti-Inflammatory Agents; Barbiturates; Biological Availability; Cholestyramine Resin; Coumarins; Drug Interactions; Humans; Metronidazole; Phenylbutazone; Rifampin; Sulfonamides; Tolbutamide | 1979 |
Rifampin disposition in the horse: effects of repeated dosage of rifampin or phenylbutazone.
Topics: Administration, Oral; Animals; Drug Administration Schedule; Female; Horses; Injections, Intravenous; Male; Phenylbutazone; Rifampin | 1992 |
Countergradients of nonchemotactic ligands for N-formylmethionylleucylphenylalanine (FMLP) receptors promote FMLP-induced chemotaxis.
Topics: Binding, Competitive; Chemotaxis, Leukocyte; Fusidic Acid; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenylbutazone; Receptors, Formyl Peptide; Receptors, Immunologic; Rifampin; Sulfasalazine; Sulfinpyrazone | 1986 |
Interactions between chloramphenicol, acepromazine, phenylbutazone, rifampin and thiamylal in the horse.
Topics: Acepromazine; Animals; Anti-Bacterial Agents; Chloramphenicol; Drug Interactions; Enzyme Induction; Female; Horses; Male; Mixed Function Oxygenases; Phenylbutazone; Rifampin; Thiamylal | 1989 |
Rifampicin and cysteamine protect against the mushroom toxin phalloidin.
Topics: Animals; Antitoxins; Chlortetracycline; Cysteamine; Cytochrome c Group; Erythromycin; Female; Guanidines; Lethal Dose 50; Liver; Mice; Mushroom Poisoning; Mycotoxins; Penicillin G; Phenylbutazone; Rats; Reserpine; Rifampin | 1974 |
Antagonistic effects to phalloidin, alpha-amanitin and extracts of Amanita phalloides.
Topics: Animals; Basidiomycota; Chloramphenicol; Estradiol; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Mycotoxins; Oligopeptides; Penicillin G; Peptides, Cyclic; Phenylbutazone; Plant Extracts; Prednisolone; Rifampin; Sulfadimethoxine; Sulfamethoxazole; Testosterone; Thioctic Acid; Time Factors; Trimethoprim | 1971 |
The influence of anti-inflammatory and immunosuppressant drugs on Nystatin induced oedema.
Topics: Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Arthritis; Aspirin; Azathioprine; Chloramphenicol; Cyclophosphamide; Dexamethasone; Drug Antagonism; Edema; Hydrocortisone; Immunosuppressive Agents; Indomethacin; Inflammation; Male; Mefenamic Acid; Mercaptopurine; Nystatin; Phenylacetates; Phenylbutazone; Prednisolone; Rats; Rifampin; Triamcinolone | 1971 |
A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro.
Topics: Alkaline Phosphatase; beta-Naphthoflavone; Caffeine; Carbamazepine; Carcinoma, Hepatocellular; Clofibrate; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; Hormone Antagonists; Humans; Isoniazid; Mifepristone; Mixed Function Oxygenases; Phenobarbital; Phenylbutazone; Phenytoin; Receptors, Glucocorticoid; Recombinant Proteins; Rifampin; Tumor Cells, Cultured; Xenobiotics | 1999 |